Symbols / PETS Stock $1.82 +2.25% PetMed Express, Inc.

Healthcare • Pharmaceutical Retailers • United States • NMS
PETS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Pharmaceutical Retailers
CEO Ms. Leslie C. G. Campbell
Exch · Country NMS · United States
Market Cap 38.89M
Enterprise Value 18.03M
Income -64.87M
Sales 186.96M
FCF (ttm) -18.37M
Book/sh 1.53
Cash/sh 1.00
Employees 173
Insider 10d —
IPO Apr 26, 1999
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -60.67
PEG 2.32
P/S 0.21
P/B 1.19
P/C —
EV/EBITDA -0.63
EV/Sales 0.10
Quick Ratio 0.52
Current Ratio 0.89
Debt/Eq 1.85
LT Debt/Eq —
EPS (ttm) -2.74
EPS next Y -0.03
EPS Growth —
Revenue Growth -7.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-06-02
ROA -20.32%
ROE -100.61%
ROIC —
Gross Margin 27.53%
Oper. Margin -13.29%
Profit Margin -34.70%
Shs Outstand 21.37M
Shs Float 13.93M
Insider Own 16.53%
Instit Own 44.97%
Short Float 3.67%
Short Ratio 8.18
Short Interest 579.29K
52W High 4.32
vs 52W High -57.87%
52W Low 1.57
vs 52W Low 15.92%
Beta 0.79
Impl. Vol. 1.51%
Rel Volume 1.81
Avg Volume 106.47K
Volume 192.50K
Target (mean) $2.15
Tgt Median $2.15
Tgt Low $2.15
Tgt High $2.15
# Analysts 1
Recom None
Prev Close $1.78
Price $1.82
Change 2.25%
About

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.15
Mean price target
2. Current target
$1.82
Latest analyst target
3. DCF / Fair value
$-15.48
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.82
Low
$2.15
High
$2.15
Mean
$2.15

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-04-17 main Morgan Stanley Underweight → Underweight $3
2024-08-07 down Lake Street Buy → Hold $4
2024-06-12 main Lake Street Buy → Buy $7
2024-06-12 main Morgan Stanley Underweight → Underweight $4
2023-11-16 main Morgan Stanley Underweight → Underweight $7
2023-10-31 main Morgan Stanley Underweight → Underweight $7
2023-10-19 main Morgan Stanley Underweight → Underweight $10
2023-07-27 reit Morgan Stanley Underweight → Underweight $17
2023-05-25 init Lake Street — → Buy $20
2023-03-23 main Morgan Stanley — → Underweight $17
2022-11-08 main Morgan Stanley — → Underweight $18
2022-07-26 main Morgan Stanley — → Underweight $19
2022-05-10 main Morgan Stanley — → Underweight $20
2022-01-25 main Morgan Stanley — → Underweight $21
2022-01-20 up Sidoti & Co. Neutral → Buy $32
2021-11-18 init Morgan Stanley — → Underweight $25
2021-10-01 init Jefferies — → Hold $28
2021-06-03 down Sidoti & Co. Buy → Neutral $39
2021-03-05 up Sidoti & Co. Neutral → Buy —
2020-08-19 up Sidoti & Co. Neutral → Buy $41
News
RSS: Latest PETS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-10-30 FULGONI GIAN M Director — 33,846 $0.00 $0
2025-10-30 MENNEN JUSTIN L. Director — 33,846 $0.00 $0
2025-10-30 LACAMP JAMES Director — 34,866 $0.00 $0
2025-10-30 SOLIVAN LEAH A. Director — 33,846 $0.00 $0
2025-10-30 BATUSHANSKY PETER Director — 33,846 $0.00 $0
2025-10-30 KRULIK DOUGLAS Chief Financial Officer — 20,000 $0.00 $0
2025-09-09 KRULIK DOUGLAS Officer — 10,000 $0.00 $0
2025-08-13 SILVERCAPE INVESTMENTS LTD. Beneficial Owner of more than 10% of a Class of Security — 101,000 $3.17 $320,170
2025-08-01 SILVERCAPE INVESTMENTS LTD. Beneficial Owner of more than 10% of a Class of Security — 118,200 $3.21 $379,422
2025-07-21 NINA CAPITAL HOLDINGS INC Beneficial Owner of more than 10% of a Class of Security — 25,000 $3.50 $87,425
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2026-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
179.02
-34.69%
274.10
+10.71%
247.57
-9.08%
272.28
Operating Revenue
179.02
-34.69%
274.10
+10.71%
247.57
-9.08%
272.28
Cost Of Revenue
128.81
-31.97%
189.33
+10.67%
171.07
-12.43%
195.34
Reconciled Cost Of Revenue
128.81
-31.97%
189.33
+10.67%
171.07
-12.43%
195.34
Gross Profit
50.22
-40.76%
84.77
+10.81%
76.50
-0.57%
76.94
Operating Expense
81.63
-12.16%
92.93
+31.91%
70.45
+33.81%
52.65
Selling General And Administration
72.24
-15.87%
85.87
+28.35%
66.90
+34.04%
49.91
Selling And Marketing Expense
21.51
-29.77%
30.63
+21.59%
25.19
+34.00%
18.80
General And Administrative Expense
50.73
-8.17%
55.25
+32.44%
41.71
+34.07%
31.11
Other Gand A
50.73
-8.17%
55.25
+32.44%
41.71
+34.07%
31.11
Total Expenses
210.44
-25.45%
282.26
+16.87%
241.52
-2.61%
247.99
Operating Income
-31.41
-284.89%
-8.16
-234.89%
6.05
-75.09%
24.29
Total Operating Income As Reported
-58.67
-618.86%
-8.16
-234.89%
6.05
-75.09%
24.29
EBITDA
-22.03
-1891.68%
-1.11
-111.52%
9.60
-64.49%
27.03
Normalized EBITDA
5.23
+572.88%
-1.11
-111.52%
9.60
-64.49%
27.03
Reconciled Depreciation
9.39
+33.04%
7.06
+98.98%
3.55
+29.51%
2.74
EBIT
-31.41
-284.89%
-8.16
-234.89%
6.05
-75.09%
24.29
Total Unusual Items
-27.26
—
—
—
Total Unusual Items Excluding Goodwill
-27.26
—
—
—
Special Income Charges
-27.26
—
—
—
Net Income
-57.29
-667.50%
-7.46
-245.21%
5.14
-72.54%
18.72
Pretax Income
-57.36
-814.38%
-6.27
-184.26%
7.45
-69.22%
24.18
Net Non Operating Interest Income Expense
0.51
+0.00%
0.51
+13.56%
0.45
+139.79%
-1.13
Net Interest Income
0.51
—
0.45
+139.79%
-1.13
Interest Income Non Operating
—
—
0.45
+34.33%
0.34
Interest Income
—
—
0.45
+34.33%
0.34
Other Income Expense
-26.45
-2019.81%
1.38
+45.97%
0.94
-7.99%
1.03
Other Non Operating Income Expenses
0.80
-41.73%
1.38
+45.97%
0.94
-7.99%
1.03
Tax Provision
-0.07
-106.13%
1.19
-48.33%
2.31
-57.85%
5.47
Tax Rate For Calcs
0.00
-99.39%
0.00
-32.26%
0.00
+36.56%
0.00
Tax Effect Of Unusual Items
-0.03
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-57.29
-667.50%
-7.46
-245.21%
5.14
-72.54%
18.72
Net Income From Continuing Operation Net Minority Interest
-57.29
-667.50%
-7.46
-245.21%
5.14
-72.54%
18.72
Net Income From Continuing And Discontinued Operation
-57.29
-667.50%
-7.46
-245.21%
5.14
-72.54%
18.72
Net Income Continuous Operations
-57.29
-667.50%
-7.46
-245.21%
5.14
-72.54%
18.72
Normalized Income
-30.06
-302.77%
-7.46
-245.21%
5.14
-72.54%
18.72
Net Income Common Stockholders
-57.29
-667.50%
-7.46
-245.21%
5.14
-72.54%
18.72
Diluted EPS
-2.74
-640.54%
-0.37
-3800.00%
0.01
—
Basic EPS
-2.74
-640.54%
-0.37
-3800.00%
0.01
—
Basic Average Shares
20.92
+2.58%
20.40
+0.60%
20.27
—
Diluted Average Shares
20.92
+2.58%
20.40
+0.28%
20.34
—
Diluted NI Availto Com Stockholders
-57.29
-667.50%
-7.46
-245.21%
5.14
-72.54%
18.72
Depreciation Amortization Depletion Income Statement
9.39
+33.04%
7.06
+98.98%
3.55
+29.51%
2.74
Depreciation And Amortization In Income Statement
9.39
+33.04%
7.06
+98.98%
3.55
+29.51%
2.74
Depreciation Income Statement
—
—
3.55
+29.51%
2.74
Total Other Finance Cost
-0.51
+0.00%
-0.51
-13.56%
-0.45
-139.79%
1.13
Line Item Trend 2026-03-31 2024-03-31 2023-03-31 2022-03-31
Total Assets
81.19
-52.21%
169.88
+1.44%
167.48
-6.80%
179.70
Current Assets
43.56
-53.48%
93.65
-28.20%
130.43
-13.62%
151.00
Cash Cash Equivalents And Short Term Investments
21.41
-61.28%
55.30
-46.87%
104.09
-6.30%
111.08
Cash And Cash Equivalents
21.41
-61.28%
55.30
-46.87%
104.09
-6.30%
111.08
Receivables
1.91
-41.88%
3.28
+88.68%
1.74
-9.04%
1.91
Accounts Receivable
1.91
-41.88%
3.28
+88.68%
1.74
-9.04%
1.91
Gross Accounts Receivable
1.93
-45.64%
3.56
+100.34%
1.77
-9.07%
1.95
Allowance For Doubtful Accounts Receivable
-0.03
+90.84%
-0.27
-680.00%
-0.04
+10.26%
-0.04
Inventory
13.61
-52.35%
28.56
+50.11%
19.02
-41.39%
32.45
Finished Goods
—
—
19.02
-41.39%
32.45
Prepaid Assets
0.26
+37.23%
0.19
-78.22%
0.86
+26.73%
0.68
Other Current Assets
6.38
+0.84%
6.33
+34.03%
4.72
-3.02%
4.87
Total Non Current Assets
37.63
-50.64%
76.24
+105.78%
37.05
+29.07%
28.70
Net PPE
26.84
-4.45%
28.09
+7.30%
26.18
+7.01%
24.46
Gross PPE
58.75
+21.84%
48.22
+16.44%
41.41
+14.55%
36.15
Accumulated Depreciation
-31.91
-58.55%
-20.13
-32.15%
-15.23
-30.35%
-11.69
Properties
0.00
0.00
0.00
0.00
Land And Improvements
3.70
+0.00%
3.70
+0.00%
3.70
+0.00%
3.70
Buildings And Improvements
19.51
+0.00%
19.51
+3.15%
18.91
+6.07%
17.83
Machinery Furniture Equipment
35.03
+48.58%
23.57
+25.43%
18.80
+28.57%
14.62
Other Properties
0.51
-64.25%
1.43
—
—
Goodwill And Other Intangible Assets
5.49
-85.50%
37.86
+4302.44%
0.86
+0.00%
0.86
Goodwill
0.00
-100.00%
26.66
0.00
—
Other Intangible Assets
5.49
-51.00%
11.20
+1202.67%
0.86
—
Investments And Advances
5.30
+0.00%
5.30
+6.00%
5.00
—
Other Investments
5.30
+0.00%
5.30
+6.00%
5.00
—
Non Current Deferred Assets
—
4.99
-0.46%
5.01
+48.24%
3.38
Non Current Deferred Taxes Assets
—
4.99
-0.46%
5.01
+48.24%
3.38
Total Liabilities Net Minority Interest
52.25
-28.57%
73.15
+27.20%
57.51
+2.25%
56.25
Current Liabilities
52.03
-27.89%
72.16
+25.47%
57.51
+2.25%
56.25
Payables And Accrued Expenses
50.85
-26.40%
69.10
+20.14%
57.51
+2.25%
56.25
Payables
43.41
-31.80%
63.64
+20.76%
52.70
+0.72%
52.33
Accounts Payable
20.91
-43.53%
37.02
+46.87%
25.21
-8.33%
27.50
Dividends Payable
0.00
-100.00%
1.47
+16.16%
1.26
+126.16%
0.56
Current Accrued Expenses
7.45
+36.59%
5.45
+13.32%
4.81
+22.67%
3.92
Total Tax Payable
22.50
-10.55%
25.15
-4.11%
26.23
+8.09%
24.27
Income Tax Payable
0.02
—
—
—
Current Debt And Capital Lease Obligation
0.49
+7.41%
0.46
—
—
Current Capital Lease Obligation
0.49
+7.41%
0.46
0.00
—
Current Deferred Liabilities
0.69
-73.53%
2.60
0.00
—
Current Deferred Revenue
0.69
-73.53%
2.60
0.00
—
Total Non Current Liabilities Net Minority Interest
0.22
-78.19%
0.99
0.00
0.00
Long Term Debt And Capital Lease Obligation
0.04
-95.78%
0.99
0.00
—
Long Term Capital Lease Obligation
0.04
-95.78%
0.99
0.00
—
Non Current Deferred Liabilities
0.17
—
0.00
-100.00%
0.94
Non Current Deferred Taxes Liabilities
0.17
—
0.00
-100.00%
0.94
Other Non Current Liabilities
—
—
3.83
—
Stockholders Equity
28.94
-70.08%
96.73
-12.04%
109.97
-10.92%
123.45
Common Stock Equity
28.93
-70.09%
96.72
-12.04%
109.96
-10.92%
123.44
Capital Stock
0.03
+0.00%
0.03
+0.00%
0.03
+0.00%
0.03
Common Stock
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Preferred Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Share Issued
21.39
+1.12%
21.15
+0.31%
21.08
+0.50%
20.98
Ordinary Shares Number
21.39
+1.12%
21.15
+0.31%
21.08
+0.50%
20.98
Additional Paid In Capital
19.65
-21.87%
25.15
+37.58%
18.28
+56.75%
11.66
Retained Earnings
9.26
-87.05%
71.56
-21.93%
91.66
-17.99%
111.76
Total Equity Gross Minority Interest
28.94
-70.08%
96.73
-12.04%
109.97
-10.92%
123.45
Total Capitalization
28.94
-70.08%
96.73
-12.04%
109.97
-10.92%
123.45
Working Capital
-8.47
-139.41%
21.49
-70.53%
72.92
-23.04%
94.75
Invested Capital
28.93
-70.09%
96.72
-12.04%
109.96
-10.92%
123.44
Total Debt
0.54
-63.20%
1.45
0.00
—
Capital Lease Obligations
0.54
-63.20%
1.45
0.00
—
Net Tangible Assets
23.45
-60.16%
58.87
-46.04%
109.11
-11.00%
122.59
Tangible Book Value
23.44
-60.17%
58.86
-46.05%
109.10
-11.00%
122.58
Other Inventories
13.61
-52.35%
28.56
+50.11%
19.02
-41.39%
32.45
Preferred Shares Number
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Preferred Stock Equity
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Line Item Trend 2026-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
-28.39
-757.73%
4.32
-84.47%
27.80
+50.30%
18.50
Cash Flow From Continuing Operating Activities
-28.39
-757.73%
4.32
-84.47%
27.80
+50.30%
18.50
Net Income From Continuing Operations
-57.29
-667.50%
-7.46
-245.21%
5.14
-72.54%
18.72
Depreciation Amortization Depletion
9.39
+33.04%
7.06
+98.98%
3.55
+29.51%
2.74
Depreciation
—
5.20
+48.57%
3.50
+29.63%
2.70
Amortization Cash Flow
—
2.00
0.00
0.00
Depreciation And Amortization
9.39
+33.04%
7.06
+98.98%
3.55
+29.51%
2.74
Amortization Of Intangibles
—
2.00
0.00
0.00
Stock Based Compensation
1.36
-80.13%
6.87
+3.81%
6.62
+45.46%
4.55
Asset Impairment Charge
29.35
+8958.02%
0.32
+51.40%
0.21
+29.70%
0.17
Deferred Tax
-2.82
-1064.38%
0.29
+117.91%
-1.63
-92.67%
-0.85
Deferred Income Tax
-2.82
-1064.38%
0.29
+117.91%
-1.63
-92.67%
-0.85
Change In Working Capital
-8.39
-204.06%
-2.76
-119.83%
13.92
+303.93%
-6.82
Change In Receivables
0.45
+125.55%
-1.74
-4148.78%
-0.04
-108.06%
0.51
Changes In Account Receivables
0.45
+125.55%
-1.74
-4148.78%
-0.04
-108.06%
0.51
Change In Inventory
0.47
+107.34%
-6.42
-147.77%
13.43
+583.56%
1.97
Change In Prepaid Assets
-1.01
-305.51%
0.49
+1500.00%
-0.04
+58.82%
-0.09
Change In Payables And Accrued Expense
-6.90
-230.72%
5.28
+842.32%
0.56
+106.08%
-9.21
Change In Accrued Expense
-4.30
-1658.70%
0.28
-69.20%
0.90
+1063.44%
-0.09
Change In Payable
-2.60
-151.91%
5.00
+1588.39%
-0.34
+96.32%
-9.12
Change In Account Payable
-2.66
-143.56%
6.10
+366.23%
-2.29
+80.98%
-12.05
Change In Other Working Capital
-1.40
-257.95%
-0.39
—
—
Change In Other Current Assets
0.45
-42.39%
0.79
0.00
0.00
Change In Other Current Liabilities
-0.46
+39.82%
-0.77
0.00
0.00
Investing Cash Flow
-4.62
+88.65%
-40.67
-296.39%
-10.26
-485.62%
-1.75
Cash Flow From Continuing Investing Activities
-4.62
+88.65%
-40.67
-296.39%
-10.26
-485.62%
-1.75
Net PPE Purchase And Sale
-4.62
-2.31%
-4.51
+14.24%
-5.26
-200.23%
-1.75
Purchase Of PPE
-4.62
-2.31%
-4.51
+14.24%
-5.26
-200.23%
-1.75
Capital Expenditure
-4.62
-2.31%
-4.51
+14.24%
-5.26
-200.23%
-1.75
Net Business Purchase And Sale
0.00
+100.00%
-36.16
-623.18%
-5.00
0.00
Purchase Of Business
0.00
+100.00%
-36.16
-623.18%
-5.00
0.00
Financing Cash Flow
-0.30
+97.60%
-12.44
+49.31%
-24.54
-0.63%
-24.38
Cash Flow From Continuing Financing Activities
-0.30
+97.60%
-12.44
+49.31%
-24.54
-0.63%
-24.38
Net Common Stock Issuance
—
—
—
0.00
Common Stock Payments
—
—
—
0.00
Common Stock Dividend Paid
—
—
-24.54
-0.63%
-24.38
Cash Dividends Paid
-0.02
+99.83%
-12.44
+49.31%
-24.54
-0.63%
-24.38
Repurchase Of Capital Stock
—
—
—
0.00
Net Other Financing Charges
-0.28
—
—
—
Changes In Cash
-33.31
+31.73%
-48.79
-597.60%
-6.99
+8.43%
-7.64
Beginning Cash Position
54.72
-47.43%
104.09
-6.30%
111.08
-6.43%
118.72
End Cash Position
21.41
-61.28%
55.30
-46.87%
104.09
-6.30%
111.08
Free Cash Flow
-33.01
-16914.95%
-0.19
-100.86%
22.54
+34.62%
16.75
Income Tax Paid Supplemental Data
0.05
-60.00%
0.13
-96.99%
4.31
-29.14%
6.08
Change In Income Tax Payable
0.06
+105.63%
-1.10
-156.29%
1.96
-33.20%
2.93
Change In Tax Payable
0.06
+105.63%
-1.10
-156.29%
1.96
-33.20%
2.93
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category